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Abstract 
Knowledge of the functional organization of the GABAergic system, the main inhibitory 
neurotransmitter system, in the CNS has increased remarkably in recent years. In 
particular, substantial progress has been made in elucidating the molecular mechanisms 
underlying formation and plasticity of GABAergic synapses. Evidence available ascribes 
a key role to the cytoplasmic protein gephyrin to form a postsynaptic scaffold anchoring 
GABAA receptors along with other transmembrane proteins and signaling molecules in 
the postsynaptic density. However, the mechanisms of gephyrin scaffolding remain 
elusive, notably because gephyrin can auto-aggregate spontaneously and lacks PDZ 
protein interaction domains found in a majority of scaffolding proteins. In addition, the 
structural diversity of GABAA receptors, which are pentameric channels encoded by a 
large family of subunits, has been largely overlooked in these studies. Finally, the role of 
the dystrophin-glycoprotein complex, present in a subset of GABAergic synapses in 
cortical structures, remains ill-defined. In this review, we discuss recent results derived 
mainly from the analysis of mutant mice lacking a specific GABAA receptor subtype or a 
core protein of the GABAergic postsynaptic density (neuroligin-2, collybistin), 
highlighting the molecular diversity of GABAergic synapses and its relevance for brain 
plasticity and function. In addition, we discuss the contribution of the dystrophin-
glycoprotein complex to the molecular and functional heterogeneity of GABAergic 
synapses. 
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Introduction 
Early electron microscopy studies uncovered a fundamental dichotomy in the ultrastructure of 
synapses in vertebrate CNS, classified as type I (asymmetric) and type II (symmetric) synapses, 
based on the width of their electron-dense postsynaptic density (PSD) [1]. Subsequently, 
identification of glutamate (and aspartate) and GABA (and glycine) as neurotransmitters in the 
CNS, combined with the advent of immunohistochemistry, showed that this dichotomy 
corresponds to excitatory and inhibitory synapses, respectively. This structural and 
neurochemical distinction reflects major differences in biochemical composition of the PSD in 
both types of synapses. The PSD contains distinct sets of scaffolding proteins associated with 
neurotransmitter receptors and signaling molecules. Biochemical fractionation revealed hundreds 
of proteins in the PSD of glutamatergic synapses. These include numerous PDZ domain-
containing scaffolding proteins, notably PSD-95 and other members of the family of membrane-
associated guanylate kinase proteins (MAGUKs) [2]. The PDZ interaction motifs are a 
characteristic feature of many scaffolding proteins, allowing to build modular protein complexes 
[3], thereby ensuring rapid, efficient, and site-specific propagation of incoming synaptic inputs 
[4]. The phototransduction complex assembled by INAD in Drosophila photoreceptors is a 
prototypical example of such signaling scaffold organized by PDZ motifs [5]. 
In glutamatergic synapses, MAGUKS play a key role in assembly and regulation of the PSD 
[6,7]. MAGUKS are membrane-anchored by specific lipid modifications (e.g., palmitoylation) 
and/or interact with components of the cytoskeleton to ensure long-term structural stability of the 
PSD [8,9]. In addition, they contribute to plasticity of synaptic transmission, mainly by binding to 
specific effector proteins, which induce posttranslational modifications regulating the trafficking 
and function of neurotransmitter receptors and other signaling molecules. Given the central role 
of PSD scaffolding molecules, even minor alterations in their expression, trafficking, regulation, 
or function have been associated with brain disease [7,10-12]. Therefore, identifying and 
correcting these dysfunctions might provide promising new avenues for drug therapy. 
In striking contrast with type I synapses, the PSD of GABAergic and glycinergic synapses 
contains only few proteins with a PDZ domain. Rather, they are organized around a core 
scaffolding protein, gephyrin, which forms multimeric complexes by auto-aggregation and by 
interacting with other postsynaptic proteins, including GABAA receptors (GABAAR), glycine 
receptors (GlyR), neuroligins (NL), and collybistin (CB) [13]. Models to explain the formation 
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and maintenance of either glycinergic or GABAergic synapses are still fragmentary [14-16], 
notably because the biochemical composition of their PSD is poorly characterized and because 
gephyrin structure is only partially resolved. The paucity of PDZ domains in proteins forming 
GABAergic and glycinergic PSDs implies, however, that protein-protein interactions are based 
largely on other motifs. While the binding site of the GlyR β subunit intracellular loop to 
gephyrin has been well characterized [17,18], much less is known about GABAAR subunits, 
although information available suggests direct interactions with members of the α subunit family 
[19-21]. A major challenge for studying GABAAR-gephyrin interactions is the presence of 
multiple receptor subtypes differing in subunit composition, each of them likely interacting 
differently with gephyrin and its partners. 
PSDs typically are associated with specific subcellular compartments; glutamatergic synapses 
being formed on dendritic spines whereas GABAergic synapses occurring mainly on neuronal 
somata, dendritic shafts, and axon initial segments. Therefore, association with specific 
cytoskeletal elements and/or transmembrane proteins linked to extracellular matrix proteins likely 
is of primary relevance for the formation and maintenance of PSDs. Although gephyrin was 
characterized initially as a tubulin-binding protein, the role of the cytoskeleton for anchoring 
GABAergic and glycinergic PSDs remains largely obscure. Furthermore, PSDs interact closely 
with presynaptic terminals by means of trans-synaptic ligand/receptor protein complexes, such as 
neurexins/NLs, integrins, ephrins, cadherins, etc., raising the possibility that the subcellular 
localization of synapses is determined by specific molecular components of the PSD.  
The purpose of this review is to highlight current knowledge of proteins interacting with gephyrin 
at GABAergic synapses. We will discuss how molecular and functional heterogeneity of 
GABAergic synapses arises from these differential interactions. We will also present evidence to 
reconsider the role of gephyrin as anchoring molecule in favor of gephyrin being the hub of a 
signaling scaffold organized in concert with specific GABAAR subtypes to regulate GABAergic 
synapse function. 
 
Overview of major PSD proteins at inhibitory synapses 
Gephyrin 
At the PSD of inhibitory synapses, anchoring GABAAR and GlyR is ensured, at least in part, by a 
scaffold assembled upon self-oligomerization of gephyrin. These interactions will be discussed in 
4 
 
more detail in the following sections. Additional well-characterized proteins associated with 
gephyrin include the transmembrane protein NL2 and CB, a member of the Dbl family of 
guanine nucleotide exchange factors (GEF), discovered upon its ability to translocate gephyrin to 
the cell surface in non-neuronal cells (reviewed in [13]). A number of additional gephyrin-
interacting proteins have been reported, which are involved mainly in regulation of the 
cytoskeleton and gephyrin trafficking. So far, however, proteins directly regulating gephyrin 
auto-aggregation have not been described, despite the fact this aggregation exclusively occurs at 
postsynaptic sites. 
Gephyrin is a highly conserved molecule, whose primary role in the living kingdom is to catalyze 
the synthesis of Molybdenum cofactor (Moco) [22]. In vertebrates, gephyrin acts in addition as a 
postsynaptic scaffolding molecule, and current evidence from rodents indicates that Moco 
synthesis in brain is restricted to astrocytes [23]. Gephyrin has two major functional domains, E 
and G, linked by an unstructured C-domain, which contains most gephyrin regulatory sites and 
binding sites for interacting proteins. While the crystal structure of the G and E domains has been 
partially determined, the instability of full-length recombinant gephyrin in solution and the lack 
of information about the structure of the C-domain are major obstacles for elucidating gephyrin 
function and the mechanism of gephyrin auto-aggregation [13]. Current models posit either 
formation of hexameric gephyrin scaffolds, with 6 gephyrin molecules binding to 3 GlyR [18], or 
aggregation of gephyrin trimers, each of which is bound to one GlyR [13].  
These models of gephyrin aggregation are based on partial structural information, localization of 
the GlyR binding site in the E-domain, and identification of surface-exposed loops regulating 
gephyrin postsynaptic aggregation [13,24,18]. Although available experimental evidence does 
not allow distinguishing between them, an important outcome of gephyrin structure is its 
enzymatic activity, which requires the active sites on the G and the E domains to be in close 
spatial proximity. The model of gephyrin trimers takes this requirement into consideration [13]. 
Data from GlyR single-particle tracking experiments and gephyrin fluorescence recovery after 
photobleaching revealed that gephyrin modulates synaptic retention time and lateral mobility of 
these receptors, and that GlyR diffusion properties modulate gephyrin clustering [25,26]. 
Therefore, a dynamic exchange of gephyrin and receptors occurs in apparently stable 
postsynaptic structures. Furthermore, time-lapse recordings from neurons expressing fluorescent 
tagged gephyrin revealed that gephyrin clusters are constantly remodeled and can move in 
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dendrites over distances of several μm in concert with apposed presynaptic terminals [27]. 
Collectively, these observations are consistent with both views that gephyrin units (e.g., trimer) 
can be added and removed from the scaffold and that the gephyrin scaffold acts as a stable but 
mobile entity in dendrites. 
There are multiple splice-variants of gephyrin generated by alternative splicing of cassettes 
localized mainly in the G- and C-domain (see [13] for nomenclature). The splice variants capable 
of Moco synthesis have been identified, but they do not necessarily differ from those forming 
postsynaptic clusters in neurons; further, insertion of the G2 splice cassette, a gephyrin isoform 
expressed in both neuronal and non-neuronal tissues, prevents gephyrin aggregation and Moco 
synthesis, and has been proposed to regulate gephyrin function, synaptic localization, and 
clustering [23,25,28]. Further characterization of gephyrin splice variants, notably in the C-
domain, will be necessary to better understand the regulation of gephyrin enzymatic activity and 
clustering in different types of synapses. 
Recent evidence points to gephyrin posttranslational modification by phosphorylation as a 
mechanism regulating its postsynaptic function. Although gephyrin is a known phospho-protein 
[29], it is only in 2007 that a first report suggested that phosphorylation-dependent recruitment of 
the peptidyl-prolyl isomerase Pin1 to a site located in the C-domain regulates GlyR binding [30]. 
We have identified a novel phosphorylation site on gephyrin, Ser270, and shown that it 
selectively regulates formation of postsynaptic gephyrin clusters in vitro and in vivo under the 
control of GSK3β [31]. These findings provide a novel mechanism to regulate GABAergic 
synapse formation and function by a phosphorylation cascade activated by a plethora of extra- 
and intracellular signals and controlling basic cellular functions. 
 
Neuroligin-2 
Neurexins and NLs gained major interest upon discovery that they induce formation of synapses 
in recombinant non-neuronal cell systems. Reports of preferential distribution of NL1 in 
glutamatergic synapses and NL2 in GABAergic synapses [32-34] fuelled considerable efforts to 
elucidate their role in synapse formation and specification in the CNS. Importantly, in the context 
of the present review, NL2 has been shown to interact directly with gephyrin and this interaction 
is necessary for postsynaptic localization of gephyrin clusters at GABAergic sites [35]. 
Apparently, NL2 is absent from glycinergic synapses, whereas NL3 and NL4 have been reported 
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to be present in a subset of GABAergic and glycinergic synapses, respectively [36,37]. The 
significance of a segregated distribution of NLs to different types of synapses is not fully 
understood [38], because this apparent selectively is lost upon overexpression and because NL3 
has been reported to be present in both glutamatergic and GABAergic synapses in vivo. It is also 
likely that NLs are functionally interchangeable to some degree, as seen in targeted gene deletion 
experiments, in which the loss of a particular NL isoform appears to be compensated in part by 
another isoform [39]. Nevertheless, the significance of the NL2-gephyrin interaction was 
highlighted by a study showing that NL2 also interacts with CB, in a manner that favors 
formation and regulation of gephyrin clusters at postsynaptic sites (see below). Therefore, NL2 is 
widely considered to play a crucial role to initiate the formation of a GABAergic PSD. 
 
Collybistin 
CB is a neuron-specific Rho-GEF encoded by a single gene (ARHGEF9) subject to alternative 
splicing. In rat, there are three main CB variants, CB1-3, differing in the C-terminal region. They 
all possess three major functional domains: an N-terminal SH3 domain, encoded by a spliced 
exon (SH3+ or SH3−), a DH (or GEF) domain selectively activating the small GTPase Cdc42, and 
a PH domain (Fig. 1). Available literature is somewhat confusing about the existence and 
structure of CB variants in other species. In human, CB is also known as hPEM2 and only one 
sequence, with a C-terminus identical to rat CB3 has been described [40]. In mouse, four 
transcripts have been identified, which are largely conserved compared to human and rat CB3, 
but differ in their N-terminus (Fig. 1). The relative abundance of CB splice variants in the CNS 
and their expression pattern across different brain regions or developmental stages have not been 
investigated systematically. A recent report using antibodies recognizing the majority of CB 
isoforms (notably CB3) confirmed the localization of CB at GABAergic PSDs in most brain 
regions [41].  
The significance of CB for glycinergic and GABAergic synaptic function is underscored by the 
discovery of several loss of function mutations in ARGEF9 underlying severe forms of X-linked 
mental retardation and hyperekpleksia [42,43]. In recombinant expression systems, CB is 
essential for cell-surface translocation of gephyrin [44]. However, this function is only assumed 
by CB variants lacking the SH3 domain, mainly CB2SH3−, suggesting that the SH3 domain 
somehow controls CB activity. A plausible model posits that, in analogy to other GEFs, the SH3 
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domain exerts an auto-inhibitory effect on the DH domain (and hence on activation of Cdc-42) 
[35]. CB binds gephyrin in the C-domain, whereas the binding site of gephyrin on CB partially 
overlaps with the binding of Cdc42, which led to speculation that they might be mutually 
exclusive [45](but see [46]). A recent study suggested, however, that CB-mediated gephyrin 
postsynaptic clustering is not dependent on a functional DH domain, but requires the PH domain 
[47]. Because gephyrin postsynaptic clusters were observed in the brain of conditional Cdc42-
deficient mice, this study even concluded that Cdc42 is dispensable for gephyrin aggregation.  
In addition to gephyrin, CB interacts directly with NL2 via its SH3 domain. Based on data from 
recombinant systems, this interaction was suggested to cause a conformational change relieving 
the auto-inhibition of the DH domain, thereby facilitating cell-surface translocation of gephyrin 
and GABAAR [35]. In neurons, the activation of CBSH3+ by NL2 was postulated to facilitate 
gephyrin clustering at postsynaptic sites upon binding to phosphoinositol-3-phosphate in the cell 
membrane via its PH domain. This model received further support in a report showing that CB 
binds to GABAAR α2 (and α3) subunit and that this interaction leads to CB activation and 
translocation of trimeric CB-gephyrin-α2 subunit complexes to the cell membrane [48]. 
However, the role of NL2 was not examined in this study. Furthermore, in view of the 
multiplicity of CB isoforms and of the heterogeneity of GABAARs, which form multiple 
subtypes differing in subunit composition and cellular/subcellular localization [49], such models 
are necessarily fragmentary and do not take into account the diversity and exquisite functional 
specialization of GABAergic synapses across the CNS.  
Insight into the roles of CB isoforms for gephyrin clustering was derived from over-expression 
studies in transfected neurons, which aimed to distinguish between CB2SH3+ and CB2SH3− [50,46], 
as well as to elucidate the contribution of Cdc42, the only known substrate of CB. In both studies, 
CB over-expression contributed to stabilize gephyrin, as evidenced by a marked increase in size 
and density of postsynaptic gephyrin clusters. Interestingly, CB2SH3− facilitated the formation of 
supernumerary postsynaptic clusters, whereas CB2SH3+ favored formation of intracellular 
gephyrin aggregates, as illustrated in Figure 2. Further, deletion of the PH domain of CB2 led to 
gephyrin retention along the dendritic cytoskeleton, whereas deletion of the DH domain strongly 
interfered with gephyrin postsynaptic clustering. Finally, over-expression of Cdc42, using 
dominant negative and constitutively active mutants for comparison, revealed that Cdc42 
cooperates with CB2SH3− for postsynaptic targeting of gephyrin and that it regulates gephyrin 
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cluster size at postsynaptic sites [46]. These data add to the model proposed by Poulopoulos et al. 
[35], by unraveling distinct functions of CB2 isoforms for gephyrin transport, postsynaptic 
targeting, and regulation of postsynaptic clustering in concert with Cdc42. However, they suggest 
that the postulated conformation-dependent activation of CBSH3+ by NL2 might not be crucial for 
proper CB function at GABAergic PSDs. Further insight into the roles of CB for gephyrin 
trafficking and clustering will require the analysis of the other splice variants (CB1, CB3), as 
well as more knowledge of their expression pattern and regulation. 
 
Differences between GABAergic and glycinergic synapses 
Because gephyrin is found in both glycinergic and GABAergic synapses, it is generally 
considered that the assembly of signaling scaffolds by gephyrin is similar in both types of 
synapses. This concept is reinforced by the homology between GABAAR and GlyR, which are 
members of the family of Cys-loop ligand-gated ion channels. However, there are a number of 
important differences between the two types of synapses, which suggest that their formation and 
regulation might depend on distinct mechanisms (Table 1): 
 First, despite being closely related, GABAARs and GlyRs differ fundamentally in their affinity 
for gephyrin. Recent reports identified the binding site of the GABAAR α1-α3 subunits on the 
gephyrin E-domain and showed substantial overlap with the GlyR β subunit, albeit with a >30-
fold lower affinity [19,51]. Nevertheless, expression of a mutant GABAAR lacking the interaction 
site in the M3-M4 loop of the α3 subunit disrupted its postsynaptic clustering in cultured 
hippocampal neurons. These findings extend a previous report, which identified a gephyrin-
interaction motif in the M3-M4 intracellular loop of the α2 subunit, sufficient to direct chimeric 
GABAAR to gephyrin-rich postsynaptic sites [20].  
Second, as discussed in the next section, postsynaptic clustering of some GABAAR subtypes is 
possible in the absence of gephyrin. In contrast, GlyR postsynaptic clustering appears to be 
dependent on the presence of gephyrin clusters [52], mirroring the high affinity of their 
interaction and confirming observations that GlyR trafficking in neurons is facilitated by 
association with gephyrin [53]. 
A third major difference between GABAergic and glycinergic synapses is the dependence of 
gephyrin on CB for postsynaptic aggregation. Unexpectedly, CB-knockout (KO) mice exhibit no 
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apparent morphological and functional alteration of glycinergic synapses in the brainstem and 
spinal cord [54]. In particular, they do not show any signs of spasticity typical of hypo-
glycinergic function at birth, which are prominent in mice lacking the type 1 glycine transporter 
(GlyT1) [55]. These results indicated that CB either is dispensable for gephyrin/GlyR clustering 
at glycinergic PSDs or is functionally replaced by a homologous protein. In contrast, as detailed 
in the next section, CB deficiency produces marked alterations of gephyrin clustering at 
GABAergic postsynaptic sites. 
A fourth difference is the differential targeting of NLs to GABAergic and glycinergic synapses. 
As noted above in the section on NL2, GABAergic, but not glycinergic synapses, selectively 
contain this NL isoform, whereas NL3 and NL4 have been reported in glycinergic synapses, at 
least in the retina [37]. Since NL2 interacts with CB and gephyrin at GABAergic synapses, this 
difference in localization might explain why CB deletion does not affect the PSD of glycinergic 
synapses. 
A fifth difference is the existence of multiple, presumably dozens of GABAAR subtypes, 
differing in subunit composition in adult brain, compared to a few GlyR subtypes, assembled 
mainly from α1 or α3 and β subunit variants. The multiplicity of GABAAR underlies molecular 
and functional heterogeneity of GABAergic synapses, as well as differential targeting to 
extrasynaptic versus postsynaptic sites. There is evidence that receptors differing in α subunit 
variant are functionally not interchangeable, and that only GABAAR targeted postsynaptically 
contribute to formation of gephyrin clusters [56,57]. Therefore, interactions of GABAAR 
subtypes with gephyrin and other GABAergic PSD proteins are likely more heterogeneous and 
synapse-specific than GlyR-gephyrin interactions. These limitations are well evident in single-
particle tracking studies of GABAAR cell surface mobility, which cannot be performed on a 
uniquely identified receptor subtype. Nevertheless, evidence available indicates that diffusion 
properties and synaptic confinement of GABAARs containing the γ2 subunit are modulated by 
enhanced excitatory synaptic activity, in a Ca++-dependent manner [58]. 
Several reports suggested that, despite the tight biochemical association between GlyRs and 
gephyrin, there is no direct correlation between gephyrin availability at postsynaptic sites and 
synaptic retention time or cell-surface diffusion parameters of GlyRs in neurons. Therefore, the 
high affinity of gephyrin for the GlyR β loop trafficking does not imply a one-to-one relationship. 
It is conceivable that gephyrin scaffolds contain a limited number of binding sites for GlyR 
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[59,25,60]. Further evidence for a dissociation between GlyR and gephyrin clustering dynamics 
was provided by analyzing the interaction between gephyrin and heat-shock cognate protein 70 
(HSc70), a chaperone modulating ubiquitination of its substrates [61]. These authors showed that 
Hsc70 selectively regulates gephyrin clustering in cultured spinal cord neurons, without affecting 
GlyR clustering and cell-surface diffusion kinetics.  
 
Heterogeneity of GABAergic synapses revealed in mice with targeted gene 
deletions 
By immunofluorescence staining and immunoelectron microscopy in brain sections, gephyrin is 
selectively detected at postsynaptic sites of glycinergic and most GABAergic synapses, forming 
puncta (clusters) that are co-localized with GlyRs and GABAARs, respectively [62-65]. Initial 
observations of a functional interaction between gephyrin and GABAAR were made in γ2-KO 
mice, in which postsynaptic clustering of GABAAR and gephyrin was strongly impaired 
compared to wild-type and heterozygous littermates [66-68]. Conversely, GABAAR clustering 
was widely disrupted in neurons from gephyrin-KO mice [69]. This interdependence was later 
shown not to be absolute, as GABAAR containing the α1 subunit, for instance, can form 
postsynaptic clusters mediating synaptic transmission in the absence of gephyrin [70,71]. 
However, ablation of GABAARs by targeted deletion of an α subunit variant often results in the 
disruption of postsynaptic gephyrin clusters and formation of large intra-cellular gephyrin 
aggregates [56,72-76], confirming the dependence of gephyrin on GABAARs for postsynaptic 
localization. Importantly, in thalamic neurons expressing both α1-GABAAR postsynaptically and 
α4-GABAAR extrasynaptically, gephyrin clustering was not rescued following α1 subunit 
deletion, indicating that α4-GABAAR cannot interact with gephyrin [75,56].  
Beyond GABAARs, evidence for multiple mechanisms of gephyrin postsynaptic clustering at 
GABAergic synapses was provided by the analysis of CB- and NL2-KO mice. In particular, in 
GABAergic synapses of the forebrain and cerebellum, multiple phenotypes were observed in CB-
KO mice, ranging from disruption of both gephyrin and GABAAR clusters (e.g., CA1 pyramidal 
cells) to complete preservation of these clusters (e.g., PV+ interneurons in CA1), passing by 
partial alteration (loss of gephyrin, but not GABAAR, clusters in Purkinje cells of the cerebellum) 
[54,77]. Although preservation of gephyrin clusters might point to a functional homologue of CB, 
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the phenotype of Purkinje cells rather indicates that clustering of gephyrin and of GABAAR 
depends on different mechanisms, with only the former requiring the presence of CB. In NL2-KO 
mice, differential loss of postsynaptic clusters was observed in different subcellular 
compartments of CA1 pyramidal cells and dentate gyrus granule cells, with the main disruption 
of gephyrin and GABAAR clusters occurring on the soma, at synapses formed by basket cells 
[78,79,35]. Thus, these reports pointed to distinct clustering mechanisms for postsynaptic 
proteins of perisomatic versus dendritic GABAergic synapses. 
Further insight into GABAergic synapse heterogeneity was provided by the analysis of 
postsynaptic proteins in the hippocampal formation of α2-KO mice [74]. Focusing on CA1 
pyramidal cells, where α2-GABAAR predominate in the perisomatic area and the axon-initial 
segment [80,81], a pronounced reduction of gephyrin clusters was observed, notably on cell 
somata, on the axon-initial segment, as well as in stratum radiatum and stratum oriens (Fig. 3A). 
While this loss of gephyrin clusters was suggestive of a disruption of the PSD, only moderate 
changes in GABAergic miniature inhibitory postsynaptic currents (mIPSC) were observed in 
mice lacking α2-GABAAR, with unchanged amplitude and 40% reduction in frequency. 
Therefore, these results indicated preservation of GABAergic function despite strongly altered 
gephyrin clustering at postsynaptic sites. Analysis of α1-GABAAR and NL2 revealed that their 
presence at perisomatic postsynaptic sites was preserved in CA1 pyramidal cells of α2-KO mice 
(Fig. 3B), whereas they were absent from the axon-initial segment. This striking subcellular 
difference was correlated with the presence of the dystrophin-glycoprotein complex (DGC) in 
perisomatic synapses (Fig. 3C), suggesting that this protein complex represents an alternate 
mechanism contributing to formation and maintenance of PSD in a subset of GABAergic 
synapses [74], and confirming that perisomatic and dendritic GABAergic PSDs are molecularly 
distinct. 
 
The dystrophin-glycoprotein complex 
The DGC is a transmembrane signaling complex present in striate and cardiac muscle cells, 
kidney tubular epithelial cells, neurons, and astrocytes, linking the extracellular matrix to the 
actin cytoskeleton (reviewed in [82-84]). The DGC is essential for normal brain development and 
synaptic function and for maintaining the structural integrity of the sarcolemma. Mutations 
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affecting the formation, post-translational modification, or function of the DGC cause multiple 
forms of hereditary muscle dystrophies. While the contribution of the DGC to muscle disease has 
been thoroughly investigated, patients with Duchenne and Becker muscular dystrophies also 
show signs of cognitive impairments and learning disabilities that have been related to its 
functions in the CNS [85,83]. In neurons, dystrophin was shown initially to be present in PSD 
fraction of purified brain membranes [86]. Subsequent studies demonstrated its association with a 
subset of GABAergic synapses [87,88], where it regulates GABAAR clustering and GABAergic 
synaptic function, as well as glutamatergic synaptic plasticity (reviewed in [83,82]). In mdx mice, 
direct involvement of dystrophin in synaptic alterations has been demonstrated by dystrophin 
rescue experiments, which normalize mIPSC amplitude and frequency, as well as LTP in CA1 
pyramidal cells [89,90].  
The molecular composition of the DGC differs between muscle sarcolemma, neuromuscular 
junction, brain and retina, and astrocytes [91,92], where, for instance, the DGC is involved in 
proper membrane targeting of aquaporin 4 at end-feet in contact with brain blood vessels [93,94]. 
Common components of the DGC include α- and β-dystroglycan, full-length dystrophin 
(Dp427), sarcoglycans, a dystrobrevin isoform, and syntrophins. The predominant dystrophin 
isoform found in astrocytes is the short N-terminal variant Dp71. 
Association of the DGC with cytoplasmic signaling molecules is ensured by direct protein-
protein interactions with β-dystroglycan or dystrophin or by means of PDZ domains present in 
syntrophin isoforms. Identified partners of syntrophins include nNOS, acquaporin 4, voltage-
gated Na+ and K+ channels [83], and NLs [95]. Interactions with extracellular signaling 
molecules critically depends on α-dystroglycan posttranslational modification by glycosylation. 
Consequently, mutations in glycosylating enzymes contribute to the pathogenesis of a subset of 
congenital muscle dystrophies associated with lissencephaly and mental retardation [84,96]. α-
dystroglycan function on glial end-feet appears to be especially crucial for normal brain 
development, whereas neuronal α-dystroglycan glycosylation is necessary for proper synaptic 
plasticity [97]. 
Localization of the DGC by immunofluorescence has been documented in neurons, using 
antibodies to full-length dystrophin, Dp71, utrophin, α-/β-dystroglycan, dystrobrevin, and 
syntrophins [82,98]. These studies reveal a systematic colocalization with proteins of the 
GABAergic PSD in a subset of neurons of cortical areas, including the entire cerebral cortex, 
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hippocampal formation (where Dp71 is selectively present in dentate gyrus granule cells), 
tectum, and cerebellum. In the hippocampus, the DGC appears to be restricted to principal cells, 
and is present selectively on the soma and proximal dendrites, suggesting an association with 
perisomatic synapses (formed by basket cells) [99,87]. 
It is not known, however, what determines the presence of the DGC in specific GABAergic 
synapses of cortical pyramidal cells. In primary neuronal cultures containing only few 
interneurons, we have shown that presence of a GABAergic terminal is required for the formation 
of the DGC [100], whereas both gephyrin and GABAARs can form ectopic clusters facing 
glutamatergic terminals. In vivo, it is therefore conceivable that a presynaptic factor present 
selectively in a subset of GABAergic neurons (such as basket cells, but not chandelier cells or 
dendritic-targeting interneurons in the hippocampus) induces the formation of the DGC and 
therefore entails these GABAergic synapses with distinct properties for clustering postsynaptic 
proteins. 
In the context of the present review, interaction of DGC members with GABAergic PSD proteins 
deserves particular attention. Interaction between α-dystroglycan and α-/β-neurexins by means of 
laminin-neurexin-sex hormone-binding globulin (LNS)/laminin G domains has been reported 
several years ago [101], and was proposed to compete with α-latrotoxin binding on neurexins. In 
addition, binding of synaptic scaffolding molecule (S-SCAM) to β-dystroglycan and NL2 has 
been characterized in studies showing the selective presence of S-SCAM at inhibitory synaptic 
sites [102,103]. S-SCAM has been identified for its synaptogenic role and interactions with 
NMDA-receptor subunits and NLs. Its binding to β-dystroglycan involves one of two WW 
domains, whereas binding to NL2 occurs through the second of its three PDZ domains. Recently 
S-SCAM was shown to bind also SynArfGEF, which selectively activates Arf6, a GTP-binding 
protein member of the ADP ribosylation factor family. S-SCAM is able to interact also with 
several MAGUKs (including PSD-95, SAP97 and Homer) [103]. Further, these authors showed 
that SynArfGEF also interacts with dystrophin and utrophin via its PDZ domain and that it co-
localizes with dystrophin and gephyrin at GABAergic synapses. Besides CB, SynArfGEF is only 
the second GEF identified so far in GABAergic synapses, and may represent an effector signaling 
molecule related to the DGC. Owing to the multiple effects of Arf6, the role of SynArfGEF is not 
yet determined. However, it is clear that it cannot substitute CB for gephyrin or GABAAR 
clustering at synapses containing the DGC, as shown in CB-KO mice.  
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While interactions with S-SCAM appear important for the association of the DGC with NL2 at 
GABAergic postsynaptic sites, they also provide for the possibility of cross-talk with 
glutamatergic synapses, in particular via activation of Arf6. Further, the selective association of 
S-SCAM with NL2 might be of relevance to explain the selective loss of inhibitory PSD proteins 
in perisomatic synapses of NL2-KO mice (see next section). 
 
Model of PSD protein clustering at GABAergic synapses  
Differences in PSD protein clustering properties in GABAergic synapses in relation to the 
presence or absence of the DGC indicate that models of GABAergic synapse formation and 
maintenance need to incorporate the role DGC proteins (and possibly SynArfGEF and Arf6) to 
account for published results. However, since the DGC is present in a subset of GABAergic 
synapses only, and is dispensable for GABAergic synapse formation in cultured hippocampal 
neurons [104], models of clustering that do not involve the DGC are also required. 
The models proposed here (Fig. 4) are elaborated on the basis of observations made in α1-KO, 
α2-KO, NL2-KO, CB-KO, and mdx mice and take the following considerations into account: 
1) In wild-type mice, while gephyrin, NL2, and CB likely are present in the majority of 
GABAergic synapses [41,65,32,14], a major distinction is brought about by the presence or 
absence of the DGC, as exemplified by thalamic relay neurons and cerebellar neurons (Fig. 
4A-B). Some cells, like hippocampal pyramidal cells, carry a mixture of both types of 
synapses (Fig. 4E-F). 
2) Interactions between CB, NL2, gephyrin and possibly GABAAR contribute to the formation 
of the postsynaptic scaffold (Fig. 4A-B) [14,15,50]. 
3) In synapses containing multiple α subunit variants, such as α1- and α2-subunits in 
perisomatic synapses of CA1 pyramidal cells (Fig. 4E) [74,81], it is not known whether they 
correspond to different receptor subtypes, or whether they are intermingled within single 
receptors [74].  
4) Gephyrin clustering, but not NL2 clustering, requires the presence of postsynaptic GABAAR 
(Fig. 4C-D) [105], in particular those containing the α2 subunit (Fig. 4G) [74]. 
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5) In contrast, the DGC is not altered in neurons lacking functional GABAergic transmission or 
gephyrin clusters (Fig. 4D, G) [105,74], indicating that its formation and postsynaptic 
localization is not dependent on GABAAR or gephyrin. 
6) Preservation of NL2 clustering in the absence of GABAAR and/or gephyrin suggests a 
mandatory association between NL2 and S-SCAM/β-dystroglycan complex (Fig. 4D, G) 
[102]. Further, this association raises the unresolved issue whether the DGC requires NL2 for 
localizing at GABAergic synapses. 
7) Disruption of gephyrin and GABAAR clusters in perisomatic, but not dendritic synapses of 
hippocampal neurons of NL2-KO mice [79,35] suggests that NL2 is the only NL isoform 
that interacts with S-SCAM/β-dystroglycan [102] and indicates that postsynaptic clustering 
of GABAAR requires the presence of a NL isoform. As a corollary, gephyrin cluster 
preservation in dendritic synapses of NL2 mice suggests compensation by another NL 
isoform. 
8) However, these observations cannot be generalized throughout the brain, as, for example, 
there is no loss of α1-GABAAR and gephyrin clusters in Purkinje cells of NL2-KO mice 
(personal observation); the nature of the mechanisms compensating for the absence of NL2 
in these cells in not known, but a compensation by NL3 or NL4 is not unlikely.  
9) In α2-KO mice, a possible direct interaction between α1-GABAAR and NL2 might explain 
preservation of α1-GABAAR clusters in perisomatic synapses (Fig. 4G); whereas the loss of 
gephyrin clusters in both perisomatic and dendritic synapses (not shown) reveals their 
dependence on α2-GABAARs, which interact directly with both gephyrin and CB2SH3+ [48]. 
10) Gephyrin-independent α1-GABAAR clustering has been observed in CB-KO mice [54], 
indicating that these GABAAR do not require CB for their proper localization. 
11) Absence of dystrophin, such as occurs in mdx mice, causes a partial disruption of α1- and 
α2-GABAAR clustering, but not gephyrin clustering (Fig. 4H) [87]. Therefore, the mdx 
mutation might cause loss of postsynaptic NL2 interacting via S-SCAM, whereas the 
CB2SH3+/NL2/gephyrin complex is likely preserved [35,46]. It is conceivable that the 
function of NL2 associated with the DGC is distinct from that of NL2/3 associated with CB 
and gephyrin. 
These models also incorporates the postulated functions of CB2 isoforms and Cdc42 (Fig. 4E, 
F)[35,46]:  
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1) The ability of CB2SH3− to form trimeric complexes with gephyrin and Cdc42 likely contributes 
to gephyrin postsynaptic targeting; 2) the role of membrane anchored CB2SH3+, interacting with 
NL2, gephyrin, and α2-GABAAR for PSD formation and gephyrin clustering; 3) the stabilization 
of gephyrin clusters might be mediated by membrane-anchored CB2SH3−; 4) the regulation of 
gephyrin postsynaptic cluster size and shape relies on activated (GTP-bound) Cdc-42.  
To explain the phenotype of CB-KO mice, in which a differential loss of gephyrin and GABAAR 
occurs in various cell types, the presence or absence of the DGC is not sufficient. For instance, 
α1-GABAARs are retained in Purkinje cells of CB-KO mice in the absence of gephyrin [54], 
suggesting their synaptic anchoring via the DGC and NL2. In contrast, in CA1 pyramidal cells, 
gephyrin, α1- and α2-GABAAR disappear in CB-KO mice, whereas in PV+ interneurons (and in 
thalamic VB neurons), gephyrin and α1-GABAAR are retained [77]. However, since the α2-
subunit interacts directly with CB2 [48], one might hypothesize that GABAergic synapses 
containing α2-GABAAR are selectively affected in CB-KO mice. Consequently, in CA1 
pyramidal cells, perisomatic synapses might be made of heteromeric α1/α2/β/γ2 receptors, which 
would fail to cluster in the absence of CB. 
 
Conclusions 
Taken together, the results discussed in this review indicate that GABAergic synapses are 
molecularly heterogeneous, and that this heterogeneity on the postsynaptic side largely arises 
from the multiple proteins regulating gephyrin clustering and its function as signaling scaffold at 
the PSD. Moreover, the view that gephyrin forms an inert structure anchoring GABAARs needs 
to be replaced by the concept that these receptors are required at postsynaptic sites to enable 
gephyrin clustering and to establish a signaling hub in the GABAergic PSD. Therefore, the 
diversity of GABAAR subunits likely reflects a diversity of signaling pathways operating at 
GABAergic synapses. While the precise mechanisms underlying GABAAR postsynaptic 
clustering remain to be elucidated, the models of PSD formation proposed here impart a major 
role to the neurexin/NL2 complex for specifying the location of GABAergic PSDs in relation to 
presynaptic terminals. The model is compatible with the proposed seeding role of CB/NL2 
interaction for initiating GABAAR and gephyrin clustering and for CB2/gephyrin/Cdc-42 
interactions for regulating shape and size of the PSD. Further, extending previous concepts, our 
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model introduces the DGC and its interaction with NL2 via S-SCAM as a second molecular 
complex present in a subset of GABAergic synapses, possibly under the influence of presynaptic 
factors. This molecular complex might enable gephyrin-independent α1-GABAAR clustering, 
possibly via interactions between NL2 and the α1 subunit. Moreover, the differential clustering 
of α1- and α2-GABAAR observed in mutant mice raises the possibility that these two receptor 
subtypes belong to functionally distinct signaling scaffolds in GABAergic synapses. Although 
the DGC is present at a subset of GABAergic synapses only, it might fulfill at least three major 
functions: stabilization and maintenance of GABAergic synapses, anchoring signaling molecules, 
notably those containing a PDZ domain, such as SynArfGEF or nNOS, in close vicinity to 
GABAergic synapses, transducing extracellular signals acting on dystroglycan to regulate the 
function and plasticity of GABAergic transmission. 
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Figure legends 
Figure 1: Comparison of CB isoforms in rat, human, and mouse. The three main functional 
domains are indicated; different colors denote distinct sequences in the N- or C-termini. The 
number of residues present in each domain or in each isoform is given on top of each variant. CB 
isoforms are best characterized in rat, where the existence of three splice variants (CB1-CB3) 
differing in the C-terminal domain is well established. In addition, each of CB1-CB3 variants is 
believed to be N-terminally spliced to include or exclude the SH3 domain. The C-terminal region 
of CB3 is identical to hPEM2, the only CB isoform described in human. The N-terminus of CB3 
differs slightly from that of CB1/2. In mice, the CB1-CB3 nomenclature does not apply because 
the sequence closest to rat CB3 is encoded in three variants with different N-termini, whereas the 
sequence closest to either CB1 or CB2 has a unique C-terminus. 
Figure 2: Differential effects of CB2SH3+ and CB2SH3− on the postsynaptic clustering of gephyrin; 
adapted from [46]. Primary cultures from hippocampal embryonic neurons were transfected with 
tagged cDNA constructs after 11 days-in-vitro (DIV) and processed for immunofluorescence 
staining with the markers indicated 4-7 days later. A) Control cell showing extensive co-
localization of gephyrin and α2 subunit immunofluorescence at postsynaptic sites. B) Upon 
transfection with mycCB2SH3−, there is a marked increase in the density and size of gephyrin/α2 
clusters in the soma and on dendrites, suggesting that CB2SH3− stabilizes gephyrin and favors its 
postsynaptic clustering. C-D) Similar effects were observed in neurons co-transfected with eGFP-
gephyrin and myc-CB2SH3+ (C) or myc-CB2SH3− (D); however, CB2SH3+ favored the formation of 
non-synaptic aggregates (arrows), whereas CB2SH3− led to increased density of postsynaptic 
aggregates, recognized by apposition to the presynaptic marker synapsin 1 (arrowhead). The 
formation of non-synaptic aggregates suggests saturation of molecules, such as NL2, which 
normally ensure postsynaptic localization of CB2SH3+. Scale bar, 20 μm.  
Figure 3: Loss of gephyrin clusters, but preservation of α1-subunit, NL2, and dystrophin clusters 
in perisomatic synapses of α2-KO mice; adapted from [74]. A-A') Distribution of gephyrin 
clusters in the CA1 region of the hippocampus, illustrating the strong reduction in α2-KO mice 
and the appearance of large intracellular gephyrin aggregates. B-B') Despite this effect, clustering 
of α1 subunit and NL2 was not affected around the pyramidal cell body in mutant mice, as seen 
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by triple immunofluorescence staining. The framed area is shown below in color-separated 
images. C-C') Similarly, the postsynaptic clustering of dystrophin and its colocalization with the 
α1 subunit and NL2 is not affected in α2-KO mice. Scale bars: A, 50 μm; B-C, 10 μm. 
Figure 4: Models of GABAergic PSD scaffold structure in distinct cell types of α1-KO, α2-KO, 
mdx (lacking full-length dystrophin), and wild-type mice. A-B) In wild-type mice, GABAergic 
PSDs contain GABAARs, gephyrin, and, in most cases, NL2/3, and CB2SH3+ and CB2SH3−, 
although these have not been demonstrated, for example in the thalamus (?). In a subset of 
synapses, for example in Purkinje cells, the DGC is also present, along with its interacting 
proteins S-SCAM and SynArfGEF. The PSD is anchored to the actin cytoskeleton. 
Phosphorylation sites on gephyrin and GABAARs (-P) contribute to dynamic regulation of 
GABAergic synapses. C-D) In α1-KO mice, gephyrin clusters are disrupted in neurons 
expressing α1-GABAAR, but NL2 clustering is preserved in the presence of the DGC, 
presumably via binding to S-SCAM. E-F) In CA1 pyramidal cells, distinct GABAergic PSDs are 
present on the soma and dendrites, characterized by the presence or absence of the DGC, 
respectively. These synapses contain both α1- and α2-GABAARs, or possibly receptors 
containing both subunit variants. In these cells, CB2SH3− and Cdc42 contribute to postsynaptic 
targeting of gephyrin, as well as regulation of the gephyrin scaffold shape and size. CB2SH3− 
interacts with NL2/3 and GABAARs (see [46] for details). G) In α2-KO mice, gephyrin 
clustering is disrupted in synapses containing α2-GABAAR. In perisomatic synapses of CA1 
pyramidal cells, the DGC anchors NL2 via S-SCAM, thereby preserving NL2 and α1 subunit 
clustering. H) Conversely, in mdx mice, a partial reduction of GABAAR at perisomatic synapses 
might be due to absence of NL2 linked to the DGC. Preservation of gephyrin clustering is best 
explained by the interaction between CB2/NL2/α2 subunit. Our model postulates a tight 
interaction between NL2 (black) and the DGC, whereas NL isoforms interacting with CB2SH3+ 
might be either NL2 or NL3 (dark grey).  
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Table 1. Differences between GABAergic and glycinergic synapses related to 
gephyrin 
 Feature GABAergic  Glycinergic 
1. Gephyrin-receptor 
interaction 
Low affinity (α1, α2, 
α3 subunits) 
High affinity (β subunit); insertion of the 
binding motif (residues 398-410 of the β 
subunit into a recombinant protein is 
sufficient for interaction with gephyrin [106] 
2. Receptor dependence on 
gephyrin for postsynaptic 
clustering 
Receptor subtype-
dependent (α2>>α1) 
Very high (clustering of GlyRs depends on 
gephyrin [107]) 
3. Gephyrin dependence on 
collybistin for postsynaptic 
clustering 
Variable (neuron 
and/or synapse 
dependent) 
None 
4. Neuroligin isoform present NL2 (NL3, NL4) NL4 
5. Receptor heterogeneity Numerous receptor 
subtypes (19 
subunits) 
Limited repertoire 
 
See main text for further explanations and references. 
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